Liferay Portal/DXP Web Content Template cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Liferay Portal and DXP. It has been declared as problematic. Affected by this issue is some unknown functionality of the component Web Content Template. Such manipulation leads to cross site scripting. This vulnerability is referenced as CVE-2025-43812. It is possible to launch the attack remotely. No exploit is available.
Details
A vulnerability, which was classified as problematic, has been found in Liferay Portal and DXP (version now known). Affected by this issue is some unknown processing of the component Web Content Template. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in web content template in Liferay Portal 7.4.3.4 through 7.4.3.111, and Liferay DXP 2023.Q4.0 through 2023.Q4.4, 2023.Q3.1 through 2023.Q3.8, and 7.4 GA through update 92 allows remote authenticated users to inject arbitrary web script or HTML via a crafted payload injected into a web content structure's Name text field
The advisory is shared for download at liferay.dev. This vulnerability is handled as CVE-2025-43812 since 04/17/2025. The exploitation is known to be easy. The attack may be launched remotely. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at EUVD (EUVD-2025-31659) and CERT Bund (WID-SEC-2025-2151). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Affected
- Liferay Portal
- Liferay DXP
Product
Type
Vendor
Name
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
04/17/2025 CVE reserved09/30/2025 Advisory disclosed
09/30/2025 VulDB entry created
12/12/2025 VulDB entry last update
Sources
Advisory: liferay.devStatus: Confirmed
CVE: CVE-2025-43812 (🔒)
GCVE (CVE): GCVE-0-2025-43812
GCVE (VulDB): GCVE-100-326360
EUVD: 🔒
CERT Bund: WID-SEC-2025-2151 - Liferay Portal und DXP: Mehrere Schwachstellen
Entry
Created: 09/30/2025 08:39Updated: 12/12/2025 02:04
Changes: 09/30/2025 08:39 (65), 09/30/2025 12:40 (7), 10/01/2025 02:39 (1), 12/12/2025 02:04 (11)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.